SCHEMBL3278323

SCHEMBL3278323

CCOC(=O)C(CC(=O)O)(Cc1ccc(C)c(C)c1)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
PTPRB P23467 2/20 0.40
PTPN1 P18031 1/20 0.40
ACP1 P24666 1/20 0.40
RECQL P46063 1/20 0.39
MMP8 P22894 1/20 0.39
POLB P06746 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PIN1 Q13526 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 1/20 0.35
HSP90AA1 P07900 1/20 0.35
RAB9A P51151 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3309786 0.88 ALDH1A1 (0.44) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3308215 0.88 ALDH1A1 (0.44) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3278579 0.84 ALDH1A1 (0.49) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3285475 0.84 PTPRB (0.43) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL27638292 0.83 ALDH1A1 (0.48) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3279099 0.81 ALDH1A1 (0.43) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3279493 0.80 ALDH1A1 (0.42) ALDH1A1LMNAPOLBSMN1; SMN2TSHR
SCHEMBL3959617 0.80 ALDH1A1 (0.47) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL8920728 0.78 ALDH1A1 (0.45) ALDH1A1LMNAPTPRBPTPN1ACP1
SCHEMBL3311919 0.78 GPR35 (0.39) ALDH1A1LMNAPTPRBPTPN1ACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152171-A1 CGRP Antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-06-17 US disclosed
US-7700589-B2 CGRP antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-04-20 US disclosed
US-20070244099-A1 CGRP Antagonists RUDOLF KLAUS 2007-10-18 US disclosed
EP-1558601-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
US-20040132716-A1 CGRP antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 US disclosed
WO-2004037811-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244099-A1 CGRP Antagonists CALCRL, OPRL1, CALCA ALDH1A1 695/4885LMNA 1416/4885PTPRB 3519/4885
US-20100152171-A1 CGRP Antagonists CALCRL, OPRL1, CALCA ALDH1A1 695/4885LMNA 1416/4885PTPRB 3519/4885
US-20040132716-A1 CGRP antagonists OPRL1, HTR1D, CALCA ALDH1A1 514/4885LMNA 2216/4885PTPRB 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.